Redcare Pharmacy raises 2026 revenue guidance again on strong Germany Rx momentum
Company now expects 2026 total revenue growth of 16% to 18%, from 15% to 17%. Germany Rx revenue now seen at a higher range, with adjusted EBITDA margin unchanged at 2.5% to 3.0%.
Story updates
EQS-Ad-hoc: Redcare Pharmacy N.V. / Key word(s): Forecast / Full year Redcare Pharmacy raises again full-year 2026 revenue guidance driven by strong Rx momentum in Germany 28-Sep-2026 / 13:48 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by 1 EQS News — a service of 2 EQS Group. The issuer is solely responsible for the content of this announcement.
══════════════════════════════════════════════════════════════════════════ Redcare Pharmacy raises again full-year 2026 revenue guidance driven by strong Rx momentum in Germany Sevenum, the Netherlands, September 28, 2026. Redcare Pharmacy N.V. announces that it is raising its full-year 2026 guidance for the second time this year, driven by continued strong Rx revenue momentum in Germany.
The Company now expects: • Total revenue growth of 16% to 18% (previously: 15% to 17%) • Non-Rx growth of 10% to 12% (unchanged) • Rx revenue in Germany between EUR 730 and 760 million, representing growth of 45% to 51% (previously: EUR 680 to 720 million, representing growth of 35% to 43%) • Adjusted EBITDA margin between 2.5% and 3.0% (unchanged) Contact: Irina Zhurba Investor Relations Redcare Pharmacy End of Inside Information ══════════════════════════════════════════════════════════════════════════ 28-Sep-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: 3 EQS News ══════════════════════════════════════════════════════════════════════════ Language: English Company: Redcare Pharmacy N.V. Erik de Rodeweg 11-13 5975 WD Sevenum Netherlands Phone: 0800 — 200 800 300 Fax: 0800 — 90 70 90 20 E-mail: investors@redcare-pharmacy.com Internet: ISIN: NL0012044747, DE000A19Y072 WKN: A2AR94, A19Y072 Indices: SDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX LEI Code: 529900JK6UXHY1YKZ082 EQS News ID: 2406332 End of Announcement EQS News Service 2406332 28-Sep-2026 CET/CEST References Visible links 1. 2. 3.